Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Clin Chest Med. 2014 Nov 6;36(1):13–34. doi: 10.1016/j.ccm.2014.10.002

Table 3.

NTM lung disease by species and region

North America
Location (dates) N Most Common Species
New York City, U.S.A. single institution(2000–2004) (80) 81 MAC (80%) M. abscessus /chelonae (13%) M. fortuitum (8%) M. xenopi (6%) M. kansasii (5%)
Oregon, U.S.A., state-wide population-based (2005–2006) (34) 407 MAC (85%) M. abscessus /chelonae (4%) M. xenopi (1%) M. fortuitum (<1%) M. goodi (<1%)
Toronto, Canada, single institution (2002–2003) (37) 255 MAC (69%) M. xenopi (21%) RGM (7%)
Four integrated health care delivery systems, U.S.A., in California, Colorado, Pennsylvania and Washington (1994–2006) (3) 1,865 MAC (80%) M. abscessus /chelonae (12%) M. fortuitum (6%) M. kansasii (6%) M. simiae (3%)
Charlottesville, Virginia, U.S.A., single institution (2001–2009) (38) 83 MAC (69%) M. kansasii (5%) M. xenopi (5%) M. abscessus (4%) M. fortuitum (4%)
Ontario, Canada (2010) (8) 1,294 MAC (64%) M. xenopi (23%) M. abscessus (3%) M. fortuitum (3%)
Central and South America
Location (dates) N Most Common Species
Baixada Santista region, Sao Paulo, Brazil (2000–2005) (39) 125 M. kansasii (20.8%) MAC (20%) M. fortuitum (16%)
Sao Jose do Rio Preto, Brazil (1996–2005) (40) 184 MAC (62.9%) M. fortuitum (11.4%) M. gordonae (8.5%) M. chelonae (5.7%) M. kansasii
M. abscessus (each 2.9%)
Buenos Aires Province, Argentina (2004–2010) (41) 54 MAC (48%)
M. avium (20.4%)
M. intracellu lare (27.8%)
M. kansasii (13%) M. gordonae (13%) M. fortuitum (3.7%) M. scrofulaceum (3.7%)
Rio de Janeiro, Brazil (1993–2011) (42) 127 MAC (35.4%) M. kansasii (33.1%) M. abscessus (18.9%) M. fortuitum (8.7%)
Para State, Brazil (2010–2011) (43) 29 M. massiliense (44.8%) MAC (20.7%)
M. avium (10.3%)
M. intracellulare (10.3%)
M. abscessus (6.9%) M. bolletii,
M. celatum,
M. fortuitum.
M. kansasii,
M. mariokaense (each 3.4%)
Europe
Location (dates) N Most Common Species
Southwest Ireland (1987–2000) (44) 17 MAC (82%) M. malmoense (12%) M. abscessus (6%)
France, multi-site (2001–2003) (45) 263 MAC (48%) M. xenopi (25%) M. kansasii (13%) M. abscessus (9%)
Leeds, UK (1995–1999) (46) 49 MAC (45%) M. malmoense (37%) M. xenopi (6%) M. kansasii (6%)
Nijmegen-Arnhem region, Netherlands (1999–2005) (48) 53 MAC (49%)
M. avium (45%)
M. intracellu lare (3.8%)
M. kansasii (23%) M. szulgai (7.5%) M. xenopi (5.6%)
Denmark, nation-wide (1997–2008) (5) 335 MAC (57%) M. malmoense (8.1%) M. xenopi (7.8%) M. abscessus (6.9%) M. gordonae (5.4%)
Central Greece (2004–2006) (47) 16 M. fortuitum (62.5%) MAC (25%) M. malmoense (12.5%)
Lisbon, Portugal (2008–2009) (81) 58 MAC (22.4%)
M. avium (6.9%)
M. intracellu lare (15.5%)
M. fortuitum (13.8%) M. gordonae (12.1%) M. kansasii (10.3%) M. chelonae (8.6%)
Naples, Italy (2006–2009) (82) 16 M. intracellulare (43.8%) M. kansasii (31.3%) M. xenopi (12.5%) M. fortuitum (6.3%)
Crete, Greece (2000–2009) (49) 38 MAC (40%) M. kansasii (26%) M. abscessus (8%) M. fortuitum
M. chelonae
M. gordonae (each 5%)
London, England, single institution (2000–2007, slowly growing NTM) (83) 57 M. kansasii (70%) MAC (40%) M. malmoense (9%) M. xenopi (7%)
Borders Region, Scotland (1992–2010) (50) 32 MAC (43.8%) M. malmoense (12.5%) M. chelonae (9.4%) M. gordonae (9.4%) M. nonchromog enicum
M. terrae
M. xenopi (each 6.3%)
Croatia, nation-wide (2006–2010) (51) 167 M. xenopi (28.1%) M. gordonae (20.4%) MAC (19.8%)
M. avium (14.4%)
M. intracellula re (5.4%)
M. fortuitum (11.4%)
Middle East and South Asia
Location (dates) N Most Common Species
Turkey, single institution (2004–2009) (60) 31 MAC 42%
M. intracellulare 32%
M. avium 10%
M. abscessus 16% M. kansasii 16%
Israel, single institution (2004–2010) (61) 45 M. xenopi 29% M. kansasii 20% MAC 18% M. fortuitum 9%
Saudi Arabia, sampling of several institutions (2009–2010) (62) 49 M. abscessus 30.6% M. fortuitum 28.6% MAC 16.3%
M. intracellulare 10.2%
M. avium 6.1%
M. kansasii 8.2%
Oman, sample of NTM lung disease cases from central laboratory (2006–2007) (63) 7 MAC 71.4%
M. intracellulare 28.6%
M. chimaera 28.6%
M. colombiense 14.3% M. simiae 14.3%
India, single institution (2005–2008) (64) 67 MAC 34%
M. intracellulare 22%
M. avium 4.5%
M. abscessus 22% M. simiae 22% M. fortuitum 12%
East Asia
Location (dates) N Most Common Species
Seoul, South Korea, single institution (2002–2003) (65) 195 MAC (48%)
M. intracellulare (29%)
M. avium (19%)
M. abscessus (33%) M. fortuitum (11%) M. kansasii (4%)
Seoul, South Korea, single institution (2002–2008) (84) 651 MAC 62.9% M. abscessus (26.7%) M. abscessus (26.7%)
Seoul, South Korea, single institution (2006–2010) (85) 345 MAC (76.2%)
M. avium (40.9%)
M. intracellulare (35.4%)
M. abscessus (18.2%) M. fortuitum (2.3%) M. kansasii (2.0%)
Kaohsiung City, Southern Taiwan, single institution (2004–2005) (72) 67 M. abscessus (44.8%) M. fortuitum (23.9%) MAC (14.9%) M. kansasii (13.4%)
Taipei City, Northern Taiwan, single institution (2007–2009) (74)* 252 MAC 39.7% M. chelonae-abscessus 30.2% M. kansasii 11.1% M. fortuitum 9.5%
Australia
Location (dates) N Most Common Species
Australia, national (2000) (77) 107 MAC (67.3%) M. kansasii (19.6%) M. abscessus (6.5%)
Queensland, Australia, state-wide (1999–2005) (2) 130 MAC (73.8%)
M. intracellulare (60%)
M. avium (13.8%)
M. kansasii (7.7%) M. abscessus (5.4%)
New Zealand, national (2004) (78) 47 MAC (83%) M. abscessus (9%)

MACMycobacterium avium complex

RGM – rapidly growing nontuberculous mycobacterial species

*

Included only patients whose radiographic disease pattern could be classified as cavitary, bronochiectatic, or consolidative